Washington Trust Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Washington Trust Advisors's ELV Position: Q1 2026 in Review
Washington Trust Advisors increased its Elevance Health (ELV) stake by 10% in Q1 2026, buying an estimated $6.57K and bringing the position to 220 shares worth $64.4K. The position accounts for 0.01% of the portfolio, ranked #333.
Washington Trust Advisors first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $395K in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Washington Trust Advisors held 220 shares of Elevance Health worth $64.4K as of Q1 2026.
- Washington Trust Advisors bought 20 Elevance Health shares in Q1 2026, an estimated $6.57K.
- Elevance Health made up 0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #333 holding.
- Washington Trust Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
- Washington Trust Advisors's Elevance Health position peaked at $395K in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.